These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929 [TBL] [Abstract][Full Text] [Related]
28. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study. Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242 [TBL] [Abstract][Full Text] [Related]
29. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam. Smith RB; Kroboth PD; Folan MM; Kroboth FJ; Rosanske TW Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690 [TBL] [Abstract][Full Text] [Related]
30. Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor. Warot D; Danjou P; Douillet P; Keane P; Puech AJ Therapie; 1994; 49(1):23-6. PubMed ID: 8091361 [TBL] [Abstract][Full Text] [Related]
31. No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study. Kamali F Eur J Clin Pharmacol; 1994; 47(1):71-4. PubMed ID: 7988628 [TBL] [Abstract][Full Text] [Related]
32. Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold. Spinweber CL; Johnson LC Psychopharmacology (Berl); 1982; 76(1):5-12. PubMed ID: 6123129 [TBL] [Abstract][Full Text] [Related]
33. Acute effects of triazolam on false recognition. Mintzer MZ; Griffiths RR Mem Cognit; 2000 Dec; 28(8):1357-65. PubMed ID: 11219963 [TBL] [Abstract][Full Text] [Related]
34. Triazolam and zolpidem: effects on human memory and attentional processes. Mintzer MZ; Griffiths RR Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619 [TBL] [Abstract][Full Text] [Related]
35. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096 [TBL] [Abstract][Full Text] [Related]
36. Effect of fluconazole dose on the extent of fluconazole-triazolam interaction. Varhe A; Olkkola KT; Neuvonen PJ Br J Clin Pharmacol; 1996 Oct; 42(4):465-70. PubMed ID: 8904618 [TBL] [Abstract][Full Text] [Related]
38. Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance. Mattila MJ; Idänpään-Heikkilä JJ; Törnwall M; Vanakoski J Pharmacol Toxicol; 1993 Sep; 73(3):180-5. PubMed ID: 8265524 [TBL] [Abstract][Full Text] [Related]
39. Sedative, memory, and performance effects of hypnotics. Roehrs T; Merlotti L; Zorick F; Roth T Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941 [TBL] [Abstract][Full Text] [Related]
40. Reversal by caffeine of triazolam-induced impairment of waking function. Roehrs T; Zwyghuizen-Doorenbos A; Smith D; Zorick F; Roth T Psychopharmacol Ser; 1988; 6():194-202. PubMed ID: 3217412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]